Your browser doesn't support javascript.
loading
Is pre-radiotherapy metabolic heterogeneity of glioblastoma predictive of progression-free survival?
Tensaouti, Fatima; Desmoulin, Franck; Gilhodes, Julia; Roques, Margaux; Ken, Soleakhena; Lotterie, Jean-Albert; Noël, Georges; Truc, Gilles; Sunyach, Marie-Pierre; Charissoux, Marie; Magné, Nicolas; Lubrano, Vincent; Péran, Patrice; Cohen-Jonathan Moyal, Elizabeth; Laprie, Anne.
Afiliación
  • Tensaouti F; Institut Claudius Regaud/Institut Universitaire du Cancer de Toulouse - Oncopôle, Radiation Oncology, Toulouse, France; ToNIC, Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, France. Electronic address: tensaouti.fatima@iuct-oncopole.fr.
  • Desmoulin F; ToNIC, Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, France.
  • Gilhodes J; Institut Claudius Regaud/Institut Universitaire du Cancer de Toulouse - Oncopôle, Biostatistics, Toulouse, France.
  • Roques M; CHU Toulouse, Neuroradiology, Toulouse, France; ToNIC, Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, France.
  • Ken S; Institut Claudius Regaud/Institut Universitaire du Cancer de Toulouse - Oncopôle, Engineering and Medical Physics, Toulouse, France; Inserm U1037- Centre de Recherches Contre le Cancer de Toulouse, Radiation Oncology, Toulouse, France.
  • Lotterie JA; ToNIC, Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, France; CHU Toulouse, Nuclear Medicine, Toulouse, France.
  • Noël G; ICANS - Radiation Oncology Strasbourg, France.
  • Truc G; Centre Georges-François Leclerc, Radiation Oncology, Dijon, France.
  • Sunyach MP; Centre Léon-Bérard-, Radiation oncology, Lyon, France.
  • Charissoux M; Institut du Cancer de Montpellier, Radiation Oncology, Montpellier, France.
  • Magné N; Institut de Cancérologie de la Loire Lucien Neuwirth, Radiation Oncology, Saint-Priest-en-Jarez, France.
  • Lubrano V; ToNIC, Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, France.
  • Péran P; ToNIC, Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, France.
  • Cohen-Jonathan Moyal E; Institut Claudius Regaud/Institut Universitaire du Cancer de Toulouse - Oncopôle, Radiation Oncology, Toulouse, France; Inserm U1037- Centre de Recherches Contre le Cancer de Toulouse, Radiation Oncology, Toulouse, France.
  • Laprie A; Institut Claudius Regaud/Institut Universitaire du Cancer de Toulouse - Oncopôle, Radiation Oncology, Toulouse, France; ToNIC, Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, France.
Radiother Oncol ; 183: 109665, 2023 06.
Article en En | MEDLINE | ID: mdl-37024057
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Radiother Oncol Año: 2023 Tipo del documento: Article Pais de publicación: Irlanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Radiother Oncol Año: 2023 Tipo del documento: Article Pais de publicación: Irlanda